{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038003","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2023-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.120928+00:00","generated_at":"2026-06-09T16:32:11.784366+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Xtant Medical acquires nanOss production ops from RTI Surgical for $2M cash plus contingent payments","bullets":["Acquired equipment and inventory from RTI Surgical's synthetic bone graft business for $2M cash plus contingent payments based on future nanOss product sales.","Assumed lease for the nanOss production facility in Greenville, NC.","Previously acquired nanOss distribution rights and IP from Surgalign in August 2023.","CEO Sean Browne says full control will revive and grow nanOss, improving manufacturing capabilities and cash flows."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038003","json":"https://secwatch.observer/filing/0001493152-23-038003.json","markdown":"https://secwatch.observer/filing/0001493152-23-038003.md","text":"https://secwatch.observer/filing/0001493152-23-038003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223038003/0001493152-23-038003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223038003/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T16:32:11.784366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}